Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 02, 2016. The document serves as a transaction notification regarding dealings in the company's ordinary shares by a Person Discharging Managerial Responsibilities (PDMR) and a person closely associated with them (PCA).
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is strictly a regulatory disclosure of a specific share transaction.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The filing details a non-monetary transfer of shares between family members.
Transaction Details and Commentary
- Transaction Type: Transfer of 7,829 Ordinary Shares (25 pence each, ISIN: GB0009252882).
- Parties Involved:
- Transferor: Mrs. V A Whyte (Company Secretary, PDMR).
- Transferee: Mr. I W Whyte (PCA of Mrs. V A Whyte).
- Consideration: Nil consideration (£0.00 per share).
- Date: November 02, 2016.
- Nature: The transaction represents a transfer from spouse to spouse, resulting in a receipt of shares by the PCA and a corresponding transfer by the PDMR.
Investor Verification Checklist
- Verify the total shareholding of Mrs. V A Whyte and Mr. I W Whyte post-transaction to assess insider ownership levels.
- Confirm that this nil-consideration transfer complies with the company's internal trading policies and relevant insider trading regulations.
- Note that this filing contains no operational or financial guidance; refer to the company's Form 20-F or interim reports for financial metrics.